Chengdu Kanghua Biological Products Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Hongbo Wu

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	1.3yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	2.1yrs
Yönetim Kurulu ortalama görev süresi	3.4yrs

Son yönetim güncellemeleri

Recent updates

The Market Doesn't Like What It Sees From Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Earnings Yet

Sep 13

We Think Chengdu Kanghua Biological Products (SZSE:300841) Can Stay On Top Of Its Debt

Jun 26

Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares

Feb 27

CEO

Hongbo Wu (56 yo)

1.3yrs

Görev süresi

Mr. Hongbo Wu is President & Non-Independent Director of Chengdu Kanghua Biological Products Co. Ltd. from July 16, 2024. Mr. Wu was Director of Chengdu Kanghua Biological Products Co. Ltd.from August 21,...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Wennian Wu	VP, CFO	2.1yrs	CN¥1.15m	0.17% CN¥ 12.3m
Huaigong Chen	VP & Quality Manager	6.3yrs	CN¥1.37m	0.18% CN¥ 12.9m
Wanfeng Sun	Vice President	6.3yrs	CN¥1.36m	0.11% CN¥ 7.7m
Fu Wang	Vice President	1.7yrs	CN¥786.60k	0.032% CN¥ 2.3m
Hongbo Wu	President & Non-Independent Director	1.3yrs	Veri yok	Veri yok

2.1yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim: 300841 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.1 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Wennian Wu	VP, CFO	1.3yrs	CN¥1.15m	0.17% CN¥ 12.3m
Hongbo Wu	President & Non-Independent Director	1.3yrs	Veri yok	Veri yok
Zhen Tao Wang	Chairman	6.3yrs	CN¥1.69m	10.78% CN¥ 769.0m
Qiangwei Zhang	Supervisor	3.5yrs	Veri yok	Veri yok
Shuqing Wu	Chairman of the Supervisory Board	6.3yrs	Veri yok	Veri yok
Xiongping Yu	Director	6.3yrs	CN¥120.00k	Veri yok
Xiaowen Li	Employee Representative Supervisor	3.3yrs	Veri yok	0.034% CN¥ 2.5m
Guangchang Wang	Independent Director	less than a year	Veri yok	Veri yok

3.4yrs

Ortalama Görev Süresi

41yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 300841 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.4 yıldır).

Chengdu Kanghua Biological Products Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Less than half of directors are independent

Chengdu Kanghua Biological Products Co., Ltd. Approves Board Elections

Chengdu Kanghua Biological Products Co., Ltd., Annual General Meeting, Apr 22, 2024

Less than half of directors are independent

High number of new and inexperienced directors

Chengdu Kanghua Biological Products Co., Ltd., Annual General Meeting, May 13, 2022

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.76 (vs CN¥0.90 in 3Q 2023)

Investor sentiment deteriorates as stock falls 22%

New minor risk - Share price stability

Chengdu Kanghua Biological Products Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Investor sentiment improves as stock rises 22%

The Market Doesn't Like What It Sees From Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Earnings Yet

Second quarter 2024 earnings released: EPS: CN¥1.19 (vs CN¥1.07 in 2Q 2023)

Less than half of directors are independent

Chengdu Kanghua Biological Products Co., Ltd. Approves Board Elections

Chengdu Kanghua Biological Products Co., Ltd. to Report First Half, 2024 Results on Aug 17, 2024

We Think Chengdu Kanghua Biological Products (SZSE:300841) Can Stay On Top Of Its Debt

Price target decreased by 15% to CN¥81.68

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chengdu Kanghua Biological Products Co., Ltd., Annual General Meeting, Apr 22, 2024

Now 24% undervalued after recent price drop

Chengdu Kanghua Biological Products Co., Ltd.'s (SZSE:300841) Prospects Need A Boost To Lift Shares

Investor sentiment deteriorates as stock falls 15%

New minor risk - Share price stability

Now 21% undervalued

Chengdu Kanghua Biological Products Co., Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024

Chengdu Kanghua Biological Products Co., Ltd.(SZSE:300841) dropped from Shenzhen Stock Exchange Component Index

Consensus EPS estimates fall by 11%

Third quarter 2023 earnings released: EPS: CN¥0.90 (vs CN¥1.25 in 3Q 2022)

Chengdu Kanghua Biological Products Co., Ltd. to Report Q3, 2023 Results on Oct 21, 2023

Second quarter 2023 earnings released: EPS: CN¥1.07 (vs CN¥1.35 in 2Q 2022)

Chengdu Kanghua Biological Products Co., Ltd. to Report First Half, 2023 Results on Aug 23, 2023

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥1.25 (vs CN¥2.45 in 3Q 2021)

Consensus forecasts updated

Second quarter 2022 earnings released: EPS: CN¥1.35 (vs CN¥1.12 in 2Q 2021)

Consensus forecasts updated

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Chengdu Kanghua Biological Products Co., Ltd. Approves Cash Final Dividend for the Year 2021

Price target decreased to CN¥238

High number of new and inexperienced directors

Chengdu Kanghua Biological Products Co., Ltd., Annual General Meeting, May 13, 2022

Chengdu Kanghua Biological Products Co., Ltd. Proposes Final Dividend for the Year 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥3.77 (vs CN¥1.75 in 2Q 2020)

Chengdu Kanghua Biological Products Co., Ltd. Announces Final Cash Dividend for 2020, Payable on 27 May 2021

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥1.68 (vs CN¥1.44 in 1Q 2020)

Chengdu Kanghua Biological Products Co., Ltd. to Report Fiscal Year 2020 Results on Apr 20, 2021

New 90-day low: CN¥423

Revenue and earnings miss expectations

Full year 2020 earnings released: EPS CN¥7.77

Investor sentiment improved over the past week

New 90-day low: CN¥430

New 90-day low: CN¥446

Third quarter earnings released

Chengdu Kanghua Biological Products Co., Ltd. to Report Q3, 2020 Results on Oct 22, 2020

Earnings released

Chengdu Kanghua Biological Products Co., Ltd. to Report First Half, 2020 Results on Aug 25, 2020

Chengdu Kanghua Biological Products Co., Ltd. (SZSE:300841) signed the equity transfer agreement to acquire 10% stake in Guangxi Yiyao Biological Technology Co., Ltd. from Shanghai Yuyao Biomedical Technology Co., Ltd. for CNY 28 million.

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş